Literature DB >> 10683680

Magnetic resonance imaging in five patients with a tumefactive demyelinating lesion in the central nervous system.

H C Silva1, D Callegaro, P E Marchiori, M Scaff, A M Tsanaclis.   

Abstract

Five patients with a tumefactive lesion were clinically followed from 1992 to 1993. Four patients were female; age ranged from 32 to 57 years, the duration of symptoms varied from 3 days to 3 years. Neurological examination disclosed dementia in two patients, aphasia in three, hemiparesis in four, hemihypoaesthesia in three, optical neuritis in two, tetraparesis with sensitive level and neurogenic bladder in one. MRI disclosed lesions with a hypersignal on images assessed at T2 and hyposignal at T1, and gadolinium heterogeneous enhancement; these lesions were located in the: a) temporooccipital region bilaterally and brain stem, b) frontoparietal white matter, c) basal ganglia, bilateral white matter and brain stem, d) left parietal region, e) cervical spinal cord, with enlargement of this region. Cerebral biopsy was performed in three patients; acute and subacute demyelinating disease was diagnosed by histological examination. Two patients had an evolutive diagnosis; exclusion of other pathologies and clinical and radiological improvement after corticotherapy, pointed to an inflammatory disease.

Entities:  

Mesh:

Year:  1999        PMID: 10683680     DOI: 10.1590/s0004-282x1999000600004

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  4 in total

1.  High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma.

Authors:  Philipp Kiewe; Christoph Loddenkemper; Ioannis Anagnostopoulos; Mark Reinwald; Eckhard Thiel; Agnieszka Korfel
Journal:  Neuro Oncol       Date:  2007-02-14       Impact factor: 12.300

2.  Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.

Authors:  A Cianfoni; S Niku; S G Imbesi
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

3.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

Review 4.  [MR spectroscopy in brain tumors].

Authors:  P Papanagiotou; M Backens; I Q Grunwald; G Farmakis; M Politi; C Roth; W Reith
Journal:  Radiologe       Date:  2007-06       Impact factor: 0.635

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.